Main > ONCOLOGY (**) > Lung>NSCLC>Early Stage PD-L1≥

---

Lung>NSCLC>Early Stage PD-L1≥'s subsections
(*) USA Approval Date: 2021. 10.15
1%>Treat.>PD-L1 MAb Injection>
Company
Generic Name: atezolizumab
RTM
RTM Web-Site

Lung>NSCLC>Early Stage PD-L1≥'s products
This section has no products